Our Transactions
Leadership across the largest and most complex situations
Advising
on its separation into two publicly traded companies
2025
Advising
on its pending ~$34.5 billion merger with
2025
Lead Financial Advisor
on its $12 billion sale of a portfolio of natural gas generation facilities and a virtual power plant platform to
2025
Advising
in connection with its intent to separate
into a standalone public company
2025
Advising
on the separation of its Biosciences & Diagnostics Solutions business
2025
Lead Financial Advisor
on its pending $29.1 billion sale to
2025
Advising
on its $5.1 billion
sale to
2024
Lead Left Bookrunner
$2.6 billion
Follow-on Offering
2024
Financial Advisor
on its $22.5 billion
acquisition of
2024
Sole Financial Advisor
Ad Hoc Group of First Lien Creditors on
chapter 11 restructuring of $8.1 billion of debt
2024
Lead Financial Advisor
on its €8.0 billion
acquisition of
from Vodafone Group
2024
Advised
on its ~$2.3 billion
acquisition of
2024
Independent Financial Advisor
on its acquisition of three fill-finish sites for an upfront payment of $11 billion from Novo Holdings following its $16.5 billion acquisition of Catalent
2024
Exclusive Financial Advisor
on its pending ~$35 billion
acquisition of
2024
Exclusive Financial Advisor
on its ~$12.6 billion
sale to
2024
Lead Financial Advisor
on its $11.5 billion
all-stock merger with
2024
Anouncement Date1 |
Status |
Transaction |
Value (M) |
---|---|---|---|
June 10, 2025 |
Pending |
Advising SIFI and 21 Invest SGR on the sale of SIFI to Faes Farma |
Up to ~€355 |
June 9, 2025 |
Pending |
Advising Warner Bros. Discovery on its separation into two publicly traded companies |
N/A |
June 9, 2025 |
Pending |
Advising Baker Hughes Company in the sale of their PSI Business to Crane Company |
$1,150 |
June 6, 2025 |
Pending |
Acting as Joint Bookrunner on Omada Health’s Initial Public Offering |
$150 |
June 2, 2025 |
Closed |
Advised Antares Capital on its multi-asset credit continuation fund |
$1,200 |
May 28, 2025 |
Closed |
Acted as Joint Bookrunner for Birkenstock’s Follow-On Offering |
$941 |
May 28, 2025 |
Pending |
Advising SunCoke Energy on its acquisition of Phoenix Global |
$325 |
May 28, 2025 |
Pending |
Advising SkyNRG on its investment from APG, MAM and KLM |
€300 |
May 27, 2025 |
Pending |
Advising an ad hoc group of crossholders on Astound Broadband’s recapitalization |
$5,600 |
May 22, 2025 |
Closed |
Acted as Joint Bookrunner for Hinge Health’s Initial Public Offering |
$503 |
May 19, 2025 |
Pending |
Advising Finastra and Vista Equity Partners on the sale of Finastra’s Treasury and Capital Markets Division to Apax Partners |
N/A |
May 19, 2025 |
Closed |
Advised Inflexion Private Equity Partners on its multi-asset continuation fund |
~£2,300 |
May 16, 2025 |
Closed |
Advised VIA equity on its continuation fund to acquire Continia Software |
N/A |
May 16, 2025 |
Pending |
Advising Cox Communications on its merger with Charter Communications |
~$34,500 |
May 15, 2025 |
Pending |
Advising Foot Locker on its sale to DICK’S Sporting Goods |
$2,500 |
May 14, 2025 |
Pending |
Advising GSK on its acquisition of efimosfermin from Boston Pharmaceuticals |
Up to ~$2,000 |
May 14, 2025 |
Pending |
Advising WuXi Bioligics on the sale of its Leverkusen drug product manufacturing facility |
€150 |
May 13, 2025 |
Closed |
Advised JMG Group on its strategic investment from Synova and GTCR |
N/A |
May 12, 2025 |
Pending |
Advising LS Power on the sale of a portfolio of natural gas generation facilities and a virtual power plant platform to NRG Energy |
$12,000 |
May 6, 2025 |
Pending |
Advising Peppertree Capital Management on its sale to TPG |
Up to ~$960 |
April 30, 2025 |
Pending |
Acting as exclusive financial advisor to Regulus Therapeutics on its sale to Novartis |
Up to ~$1,700 |
April 30, 2025 |
Pending |
Advising IPL on its merger with Schoeller Allibert |
N/A |
April 29, 2025 |
Pending |
Advising S&P Global in connection with its intent to separate its Mobility segment into a standalone public company |
N/A |
April 29, 2025 |
Pending |
Advising Omada on its sale to GRO Capital and Kirk Capital |
N/A |
April 16, 2025 |
Pending |
Advising NorthC and a UK DC business on the acquisition of a portfolio of eight data center facilities from Colt Technology Services |
N/A |
April 14, 2025 |
Pending |
Advising Capital Power on its acquisition of Hummel and Rolling Hills power generation assets |
~$2,200 |
April 14, 2025 |
Pending |
Advising an ad hoc group of first lien term loan holders on Cision’s recapitalization |
$2,400 |
April 10, 2025 |
Closed |
Advised U. S. Steel on its activism defense against Ancora |
N/A |
April 10, 2025 |
Closed |
Advised Litmus Software on its sale to Validity |
N/A |
April 9, 2025 |
Pending |
Advising HealthEdge on its sale to Bain Capital |
N/A |
April 9, 2025 |
Pending |
Advising EQT on the sale of a minority stake in IFS to ADIA, CPP, and Hg |
N/A |
April 8, 2025 |
Closed |
Advised Bausch Health Companies on the launch of its new senior secured credit facilities and senior secured notes |
$7,900 |
April 7, 2025 |
Pending |
Advising CVC DIF on its acquisition of a 49% interest in BALANCE Erneuerbare Energien |
N/A |
April 7, 2025 |
Pending |
Advising Woodside Energy on its sale of a 40% interest in Louisiana LNG Infrastructure to Stonepeak |
$5,700 |
April 3, 2025 |
Pending |
Advising the shareholders of Colonial Enterprises on its sale to Brookfield Infrastructure Partners |
~$9,000 |
April 2, 2025 |
Pending |
Advising Southern Water on its forward starting backstop facility and swap maturity extension |
£1,200 |
April 2, 2025 |
Pending |
Advising Dotmatics on its sale to Siemens |
$5,100 |
March 31, 2025 |
Pending |
Advising Preem on its sale to VARO Energy |
N/A |
March 27, 2025 |
Pending |
Advising Excelerate Energy on its acquisition of New Fortress Energy’s downstream LNG and Power Infrastructure business in Jamaica |
$1,055 |
March 19, 2025 |
Pending |
Advising Ampere Computing on its sale to SoftBank |
$6,500 |
March 19, 2025 |
Pending |
Advising T&D Holdings on their investment into Viridium, as part of a consortium including Allianz and BlackRock |
€3,500 |
March 19, 2025 |
Pending |
Advising OptiNose on its sale to Paratek Pharmaceuticals |
~$330 |
March 12, 2025 |
Closed |
Advised Appriss Retail on its sale to Gemspring Capital |
N/A |
March 12, 2025 |
Closed |
Acted as an Active Bookrunner on Mineralys’ Follow-on Offering |
$175 |
March 12, 2025 |
Closed |
Advised Phi Industrial Acquisitions on a continuation fund for BlueSun HoldCo |
€287 |
March 12, 2025 |
Closed |
Advised Phi Industrial on its continuation fund to acquire BlueSun HoldCo |
€287 |
March 10, 2025 |
Closed |
Advised Fundare Resources Company on the sale of its subsidiary, Moonrise Midstream, to Summit Midstream Corporation |
$90 |
March 6, 2025 |
Closed |
Advised Crestview Partners on its acquisition of Smyth Companies |
N/A |
March 6, 2025 |
Closed |
Advised Smooth-Bor on its sale to Plastiflex Group |
N/A |
March 5, 2025 |
Closed |
Acted as joint-placement agent to Lithium Americas on its Convertible Note PIPE investment from Orion Resource Partners |
$250 |
March 5, 2025 |
Pending |
Advising CoreWeave on its acquisition of Weights & Biases |
N/A |
March 3, 2025 |
Pending |
Advising Buckman Laboratories on its sale to Pritzker Private Capital |
N/A |
March 3, 2025 |
Closed |
Acted as Co-Manager to Synopsys on its senior notes offering to support the acquisition of Ansys |
$10,000 |
March 3, 2025 |
Pending |
Advising Keysight on the sale of Spirent’s High-Speed Ethernet and Network Security Business |
$425 |
February 25, 2025 |
Pending |
Advising LongRange Capital on its acquisition of US Synthetic from ChampionX |
$300 |
February 24, 2025 |
Pending |
Advising Alat on its acquisition of a minority stake in TK Elevator and establishment of a KSA based joint venture |
N/A |
February 21, 2025 |
Pending |
Advising ConocoPhillips on the sale of its interest in deepwater U.S. oil and gas assets to Shell |
$735 |
February 18, 2025 |
Closed |
Acted as an Active Bookrunner on Arcus Biosciences’ Registered Direct Offering |
$150 |
February 12, 2025 |
Pending |
Advising Riot Platforms on AI/HPC uses for its power assets at its facilities |
N/A |
February 12, 2025 |
Closed |
Acted as Placement Agent and Financial Advisor to Super Micro Computer on its Convertible Private Placement and Convertible Note Amendment |
$2,425 |
February 12, 2025 |
Closed |
Acted as an Active Bookrunner on Karman Space & Defense’s upsized Initial Public Offering |
$582 |
February 12, 2025 |
Closed |
Acted as Lead Left Bookrunner on Zurn Elkay Water Solutions’ Follow-on Offering |
$312 |
February 12, 2025 |
Closed |
Acted as an Active Bookrunner on Sailpoint’s Initial Public Offering |
$1,380 |
February 10, 2025 |
Pending |
Advising Hg on the sale of its majority stake in Trackunit to Goldman Sachs Alternatives |
N/A |
February 10, 2025 |
Pending |
Advising Kito Crosby on its sale to Columbus McKinnon |
$2,700 |
February 6, 2025 |
Pending |
Advising Zips Car Wash on its pre-arranged chapter 11 restructuring |
~$950 |
February 6, 2025 |
Closed |
Advising Rocktree Logistics Group on its acquisition of ATRIA Soluciones Logísticas and new $350mm credit facility from an affiliate of EnTrust Global |
N/A |
February 5, 2025 |
Pending |
Advising Becton Dickinson on the separation of its Biosciences & Diagnostics Solutions business |
N/A |
January 30, 2025 |
Closed |
Acted as an Active Bookrunner on Metsera’s Initial Public Offering |
$316 |
January 30, 2025 |
Pending |
Advising Viper Energy on its definitive purchase and sale agreement to acquire equity interests in certain mineral and royalty-interest owning subsidiaries of Diamondback |
~$4,450 |
January 29, 2025 |
Pending |
Advised Henry Schein on its activism defense against Ananym and a strategic investment by KKR |
N/A |
January 27, 2025 |
Pending |
Advising Evelyn Partners on the sale of its Evelyn Partners Fund Solutions business to Thesis Holdings |
N/A |
January 23, 2025 |
Pending |
Advising HTC Partners on the partial sale of its extended reality (XR) unit to Google |
$250 |
January 21, 2025 |
Closed |
Advised Ares as Preferred Lender and sponsor of the Company’s out-for-court recapitalization |
~$1,400 |
January 17, 2025 |
Pending |
Advising Better Health Group on its new money financing and debt exchange transaction |
~$843 |
January 17, 2025 |
Pending |
Advising WuXi AppTec on the sale of its U.S medical device testing operations to NAMSA |
N/A |
January 16, 2025 |
Pending |
Advising Infinidat on its sale to Lenovo |
N/A |
January 15, 2025 |
Closed |
Acted as an Active Bookrunner on Flowco’s Initial Public Offering |
$491 |
January 14, 2025 |
Closed |
Advised EMCOR Group on its acquisition of Miller Electric |
$865 |
January 14, 2025 |
Closed |
Advised Hivest Capital Partners on a continuation fund to acquire interests in Agora Makers |
N/A |
January 13, 2025 |
Closed |
Acted as Lead Global Placement Agent for the fundraise of Hildred Capital’s Fund III |
$810 |
January 10, 2025 |
Pending |
Advising Calpine on its sale to Constellation Energy |
$29,100 |
January 10, 2025 |
Pending |
Advising Alliance Pharma on its recommended acquisition from DBAY Advisors Limited |
£350 |
January 10, 2025 |
Pending |
Advising RP Management on its sale to Royalty Pharma |
~$1,100 |
January 8, 2025 |
Pending |
Advising Transcarent on its acquisition of Accolade |
$621 |
January 6, 2025 |
Pending |
Advising FuboTV on its business combination with Walt Disney’s Hulu + Live TV vMVPD business |
N/A |
January 3, 2025 |
Closed |
Advised Nu Skin on the sale of its Mavely business to Later |
~250 |
1Announcement date for M&A transactions represents the date publicly announced; announcement date for restructurings represents the date publicly announced or filed; announcement date for capital markets transactions represents the pricing date.